NCT00296569View on ClinicalTrials.gov

A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006)

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Osteoarthritis

Interventions

DRUG

MK0686

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00296569 - A Study to Assess the Safety and Efficacy of an Investigational Drug (MK-686) in Patients With Osteoarthritis (0686-006) | Biotech Hunter | Biotech Hunter